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Background
The HIV-1 epidemics in Argentina presents a higher prev-
alence of subtype B in men having sex with men and of BF
recombinant forms in injecting drug users and heterosex-
uals. Since little is known about HIV-1 dual infections in
a population with double transmission risk, the aim of
this study was to analyze the frequency of multiple infec-
tions in HIV (+) individuals from this at-risk group, by
implementing the Heteroduplex assay (HAD) as a screen-
ing methodology.
Methods
Inform consents and sequential blood samples were
obtained from 10 HIV+ patients (P) from Buenos Aires.
Partial gag and pol proviral coding regions were amplified
by Nested-PCR and the amplicons were used to perform
the HDA as described by Powell et al. (2008). Dual infec-
tions were confirmed by cloning and sequencing. Phylo-
genetic and bootscanning analysis were performed by
Neighbor-joining and Simplot. CD4 cell count, viral load
(VL) and antiretroviral (ARV) treatment were evaluated.
Results
Gag and pol PCR products were obtained from 6 out of 10
patients. Heteroduplex formation was observed for 3 of
them. Gag analysis showed that in 2 patients (P1, P2)
sequences from samples 1 and 2 clustered with B and F
references, respectively. In both cases, BF recombinant
sequences were detected. In P3, sequences from samples 1
and 2 clustered with B references, but the genetic diver-
gence between the two groups of sequences suggested that
intrasubtype dual infection may have occurred. pol
sequences analysis showed that all of them clustered
together. No significant changes were observed in CD4
and viral load values.
Conclusion
The HDA allowed us to identify the coexistence of differ-
ent sequences in this population. Further, it was possible
to detect subtype B/BF recombinants multiple infections.
These results suggest that multiple infections could be
driving viral evolution in our country, possibly complicat-
ing vaccine strategies.
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